Clinical trials: Emerging Pathogens
Prospective Studies
Detect Novel Pathogens and Characterize Emerging Infections
Infectious disease is the single biggest cause of death worldwide. New infectious agents,such as the Severe Acute Respiratory Syndrome coronavirus and new strains of influenza continually emerge and require new investigations to…
- Trial name
- NP (NCT01979705)
- Where
- Singapore
- Volunteers
- 100 people
- Sponsor
- Singapore General Hospital
Vector-Borne Diseases, Emerging Pathogens
Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing
Background: Vector-borne diseases are caused by the bite of an infected mosquito, fly, flea, tick, or other blood-feeder. These diseases cause almost 1 million deaths per year.
- Trial name
- NCT04034264
- Where
- 6 sites in Cambodia
- Volunteers
- 6,500 people, healthy volunteers welcome
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Babesioses, Human
Surveillance of Emerging Pathogens to Ensure Blood Supply Safety
Babesia is a parasite that can be transmitted from the bite of a tick to an individual. While many some people may not have any symptoms from infection, others may experience anything from flu-like symptoms to joint pain…
- Trial name
- NCT06462677
- Testing
- Babesia NAT
- Volunteers
- healthy volunteers welcome
- Sponsor
- Canadian Blood Services